Omeros

Omeros Financial Leverage

The Financial Leverage (Equity Multiplier) of Omeros (OMER) as of Oct 31, 2026 is -2.69. In the previous year, Financial Leverage (Equity Multiplier) was -1.52 — a change of 77.02% (lower).

Financial Leverage

-2.69

YoY

77.02%

Last updated:

Financial Leverage (Equity Multiplier) of Omeros is 2025 -2.69 . Financial Leverage (Equity Multiplier) of Omeros was 2024 -1.52 . It decreases by 77.02% lower compared to the previous year.

The Omeros Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
0.15 USD
Jan 1, 2019
-1.26 USD
Jan 1, 2020
-1.50 USD
Jan 1, 2021
17.63 USD
Jan 1, 2022
6.90 USD
Jan 1, 2023
-15.14 USD
Jan 1, 2024
-1.52 USD
Jan 1, 2025
-2.69 USD
The Omeros Financial Leverage history
YEARFinancial LeverageYoY
-2.69+77.02%
-1.52-89.98%
-15.14-319.53%
6.90-60.88%
17.63-1,275.97%
-1.50+19.34%
-1.26-951.39%
0.15-100.36%
-41.34+2,200.93%
-1.80-3.80%
-1.87+618.32%
-0.26—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Financial Leverage (Equity Multiplier) of Omeros is -2.69 in 2025.

Financial Leverage (Equity Multiplier) of Omeros changed from -1.52 to -2.69, representing a 77.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Omeros since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Omeros with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Omeros

All Key Metrics — Omeros